This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK610.00. The company’s shares closed last Friday at ...

The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s shares closed yesterday at DKK463.81.

Anxious not to be left behind in the haemophilia market, Novo Nordisk has forged an alliance with Bluebird Bio to apply a gene-editing approach to the bleeding disorder. The two partners have ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus ® (oral semaglutide) significantly reduced the risk of major adverse ...

The deal comes as Novo Nordisk moves to become the leader in the ... aimed at attracting more bio-manufacturing companies. Together, they've named the area The Woodlands Innovation District.

Claim your 7-day free trial now. Novo Nordisk A/S NVO on Saturday presented the full results from the Phase 3b STRIDE peripheral artery disease (PAD) outcomes trial. The study evaluated the once ...

LONDON, March 17 (Reuters) - Danish company Novo Nordisk's (NOVOb.CO), opens new tab membership in a UK pharmaceutical industry body has been restored after a two-year suspension for breaching a ...

today announced that Novo Nordisk and TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology), have entered into an exclusive license agreement for UBT251, a ...